Clinical Trials Logo

Clinical Trial Summary

Oral polio and rotavirus vaccines are significantly less effective in children living in the developing world. Tropical enteropathy, which is associated with intestinal inflammation, decreased absorption and increased permeability, may contribute substantially to oral vaccine failure in developing country settings. Other possible causes of oral vaccine underperformance include malnutrition, interference with maternal or breastmilk antibodies, changes in gut microbiota, and genetic susceptibility.

Primary Objective: to determine whether tropical enteropathy impairs the efficacy of oral polio and rotavirus vaccines in children in Bangladesh.

Secondary Objectives: 1) to determine the impact of an inactivated polio vaccine (IPV) boost on the efficacy of oral polio vaccine and 2) to determine the efficacy of oral rotavirus vaccine to prevent rotavirus diarrhea

The polio and rotavirus randomized clinical trials are embedded as secondary objectives within the exploratory study of tropical enteropathy. The primary and secondary outcome measures are relevant to the randomized clinical trials.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01375647
Study type Interventional
Source University of Vermont
Contact
Status Completed
Phase Phase 3
Start date May 2011
Completion date November 2014

See also
  Status Clinical Trial Phase
Completed NCT04110366 - Nasal and Systemic Immune Responses to Nasal Influenza Vaccine N/A
Completed NCT02992197 - The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity Phase 4
Completed NCT04941209 - imPulseā„¢ Una Infrasound-to-ultrasound E-stethoscope
Active, not recruiting NCT02477046 - Assessment of Community Transmission of Sabin Type 2 Virus in Bangladesh Phase 3